可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 崔红玉.C反应蛋白在不同类型冠心病间的差异[J].心脏杂志,2005,17(6):620.
[2] 王文清,宁波,王新宴,等.C反应蛋白与冠心病病变程度的相关性[J].心脏杂志,2006,18(3):323-325.
[3] Otsuka T, Kawada T, Katsumata M,et al.Highsensitivity Creactive protein is associated with the risk of coronary heart disease as estimated by the Framingham Risk Score in middleaged Japanese men[J].Int J Cardiol,2007,[Epub ahead of print].
[4] Okin PM, Roman MJ, Best LG,et al.CReactive protein and electrocardiographic STsegment depression additively predict mortality:The Strong Heart Study[J].J Am Coll Cardiol, 2005,45(11):1787-1793.
[5] Cushman M, Arnold AM, Psaty BM,et al.Creactive protein and the 10year incidence of coronary heart disease in older men and women:the cardiovascular health study[J].Circulation,2005,112(1):25-31.
[6] 殷忠,李兰荪,张荣庆,等.急性冠脉综合征患者外周血MMP-9及CRP的变化及其临床意义[J].心脏杂志,2006,18(3):318-319,322.
[7] 罗明,俞文萍,王宏保.辛伐他汀联合依那普利干预对急性冠脉综合征患者血清C反应蛋白和白介素-6的影响[J].心脏杂志,2005,17(2):137-139.
[8] Hartford M, Wiklund O, Mattsson Hulen L,et al.Creactive protein, interleukin6, secretory phospholipase A2 groupⅡA and intercdllular adhesion molecule1 in the prediction of late outcome events after acute coronary syndromes[J].J Intern Med, 2007,262(5):526-536.
[9] Morrow DA,de lemos JA,Sabatine MS,et al.Clinical relevance of Creactive protein during followup of patients with acute coronary syndromes in the AggrastattoZocor Trial[J].Circulation, 2006,114(4):281-288.
[10]Haim M, Benderly M, Tanne D,et al.Creactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease[J].Am Heart J,2007,154(6):1095-1101.
[11]Wilson PW, Nam BH, Pencina M,et al. Creactive protein and risk of cardiovascular disease in men and women from the framingham heart study[J].Arch Intern Med,2005,165(21):2473-2478.